Catalyst Wire Dossier Catalyst Wire Dossier

Repaglinide/metformin

repaglinide/metformin · Novo Nordisk A/S
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Repaglinide/metformin, covering 2017-02-10 to 2017-02-10. Get the full timeline:

Most recent: Clinical Trial Update: Single Dose Pharmacokinetics of Repaglinide, Metformin and Combination Tablet in Fed Healthy Volunteers [Phase 1]

See pricing